CompletedPhase 3NCT00838435

Effect of Kuvan on Neurocognitive Function, Blood Phenylalanine Level, Safety, and Pharmacokinetics in Children With PKU

Studying Classic phenylketonuria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
BioMarin Pharmaceutical
Principal Investigator
Joshua Lilienstein, M.D., M.D
BioMarin Pharmaceutical
Intervention
sapropterin dihydrochloride(drug)
Enrollment
95 enrolled
Eligibility
6 years · All sexes
Timeline
20092018

Study locations (19)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00838435 on ClinicalTrials.gov

Other trials for Classic phenylketonuria

Additional recruiting or active studies for the same condition.

See all trials for Classic phenylketonuria

← Back to all trials